Cotiviti Holdings (NYSE: COTV) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it contrast to its competitors? We will compare Cotiviti Holdings to similar businesses based on the strength of its earnings, valuation, dividends, risk, institutional ownership, profitability and analyst recommendations.
Insider and Institutional Ownership
85.8% of Cotiviti Holdings shares are owned by institutional investors. Comparatively, 66.5% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 15.8% of Cotiviti Holdings shares are owned by insiders. Comparatively, 21.4% of shares of all “Medical Software & Technology Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Cotiviti Holdings and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Cotiviti Holdings||$625.16 million||$48.85 million||32.28|
|Cotiviti Holdings Competitors||$413.25 million||-$24.61 million||395.53|
Cotiviti Holdings has higher revenue and earnings than its competitors. Cotiviti Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of recent ratings for Cotiviti Holdings and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Cotiviti Holdings Competitors||84||433||818||13||2.56|
Cotiviti Holdings currently has a consensus price target of $41.29, indicating a potential upside of 31.86%. As a group, “Medical Software & Technology Services” companies have a potential upside of 20.55%. Given Cotiviti Holdings’ stronger consensus rating and higher probable upside, research analysts clearly believe Cotiviti Holdings is more favorable than its competitors.
This table compares Cotiviti Holdings and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Cotiviti Holdings Competitors||-14.84%||-8.26%||-0.16%|
Risk and Volatility
Cotiviti Holdings has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Cotiviti Holdings’ competitors have a beta of 1.19, meaning that their average share price is 19% more volatile than the S&P 500.
Cotiviti Holdings beats its competitors on 9 of the 13 factors compared.
About Cotiviti Holdings
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Receive News & Ratings for Cotiviti Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.